Cstone pharmaceuticals co. ltd
WebCSTONE PHARMACEUTICALS. Analyst Report: Amazon.com, Inc. Amazon is a leading online retailer and one of the highest-grossing e-commerce aggregators, with $386 billion … WebCompany profile page for CStone Pharmaceuticals including stock price, company news, press releases, executives, board members, and contact information
Cstone pharmaceuticals co. ltd
Did you know?
WebCStone Pharmaceuticals Co. Ltd. 's Exposure is Medium. Low. Medium. High. Management. Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies. CStone Pharmaceuticals Co. Ltd. 's Management of ESG … WebMar 30, 2024 · Suzhou-China based Cstone Pharmaceuticals Co. Ltd., which in-licensed RET inhibitor pralsetinib from Blueprint Medicines Corp. in 2024, has won Chinese approval for the drug to treat adult patients with locally advanced or metastatic RET fusion-positive non-small-cell lung cancer (NSCLC) after platinum-based chemotherapy. Already …
WebJun 7, 2024 · Cstone Pharmaceuticals Co. Ltd.’s orally administered Tibsovo (ivosidenib tablets) received the green light from China’s NMPA for use in adult patients with relapsed/refractory acute myeloid leukemia (r/r AML) with a susceptible isocitrate dehydrogenase 1 (IDH1) mutation. It is the first IDH1 inhibitor to reach market in China. WebCStone Pharmaceuticals Profile and History. CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and internationally. It offers Sugemalimab, a monoclonal antibody against programmed …
WebMay 28, 2024 · Shanghai - CStone Pharmaceuticals Co., Ltd. ('CStone' or the 'Company', HKEX: 2616) today announced that the company released the pre-clinical data of its … WebJan 5, 2024 · CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The Company conducts its businesses mainly in …
WebFeb 24, 2024 · CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, …
WebNov 21, 2024 · SUZHOU, China, Nov. 21, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology ... Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a leading global pharmaceutical company based in … shanghai calling synopsisWebAlso Known As 基石药业, Jishi Yaoye. Legal Name CStone Pharmaceuticals Co., Ltd. Stock Symbol HKG:2616. Company Type For Profit. Contact Email [email protected]. Phone Number + 86- … shanghai calling 2012WebApr 6, 2024 · -- China's National Medical Products Administration heeft de aanvullende biologische licentieaanvraag van CStone Pharmaceuticals aanvaard voor sugemalimab als chemotherapiecombinatie bij de... 10 april 2024 shanghai calling castWebJun 7, 2024 · CStone Pharmaceuticals (OTCPK:CSPHF) (2616.HK) revenue fell 77% last year and its net loss climbed, as the Chinese drug company saw one-off license fees decline sharply and marketing costs to ... shanghai calling codeWebNov 24, 2024 · CStone Pharmaceuticals Co Ltd’s Ipilimumab Biosimilar Drug Details: Ipilimumab biosimilar (CS-1002) is under development for the treatment of solid tumors including colorectal cancer, hepatocellular carcinoma, malignant pleural mesothelioma, pancreatic adenocarcinoma, prostate cancer, gastro-intestinal stromal tumor, … shanghai cambridge dictionaryWebApr 4, 2024 · -- CStone Pharmaceuticals zegt dat de resultaten van zijn registrerende klinische studie naar sugemalimab voor de behandeling van lymfeklierkanker zijn gepubliceerd in het Journal of Clinical... 10 april 2024 shanghai candy machine co. ltdWebNov 21, 2024 · CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the unmet ... shanghai calling summary